Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

Quantifying the utilization of medical devices necessary to detect postmarket safety differences: A case study of implantable cardioverter defibrillators.

Bates J, Parzynski CS, Dhruva SS, Coppi A, Kuntz R, Li SX, Marinac-Dabic D, Masoudi FA, Shaw RE, Warner F, Krumholz HM, Ross JS.

Pharmacoepidemiol Drug Saf. 2018 Jun 12. doi: 10.1002/pds.4565. [Epub ahead of print]

PMID:
29896873
2.

Recent advances in objectifying pain using neuroimaging techniques.

Archibald J, Warner FM, Ortiz O, Todd M, Jutzeler CR.

J Neurophysiol. 2018 May 16. doi: 10.1152/jn.00171.2018. [Epub ahead of print]

PMID:
29766766
3.

Placebo response in neuropathic pain after spinal cord injury: a meta-analysis of individual participant data.

Jutzeler CR, Warner FM, Cragg JJ, Haefeli J, Richards JS, Andresen SR, Finnerup NB, Mercier C, Kramer JL.

J Pain Res. 2018 Apr 30;11:901-912. doi: 10.2147/JPR.S155979. eCollection 2018.

4.

Prevalence of chronic pain among individuals with neurological conditions.

Cragg JJ, Warner FM, Shupler MS, Jutzeler CR, Cashman N, Whitehurst DGT, Kramer JK.

Health Rep. 2018 Mar 21;29(3):11-16.

5.

Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results.

Huang C, Dhruva SS, Coppi AC, Warner F, Li SX, Lin H, Nasir K, Krumholz HM.

J Am Heart Assoc. 2017 Nov 13;6(11). pii: e007509. doi: 10.1161/JAHA.117.007509.

6.

Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression.

Richards DA, Rhodes S, Ekers D, McMillan D, Taylor RS, Byford S, Barrett B, Finning K, Ganguli P, Warren F, Farrand P, Gilbody S, Kuyken W, O'Mahen H, Watkins E, Wright K, Reed N, Fletcher E, Hollon SD, Moore L, Backhouse A, Farrow C, Garry J, Kemp D, Plummer F, Warner F, Woodhouse R.

Health Technol Assess. 2017 Aug;21(46):1-366. doi: 10.3310/hta21460.

7.

Journal Club: Long-term functional outcome in patients with acquired infections after acute spinal cord injury.

Warner FM, Tong B, Jutzeler CR, Cragg JJ, Scheuren PS, Kramer JLK.

Neurology. 2017 Aug 15;89(7):e76-e78. doi: 10.1212/WNL.0000000000004241. No abstract available.

PMID:
28808174
8.

Heterogeneity in Early Responses in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).

Dhruva SS, Huang C, Spatz ES, Coppi AC, Warner F, Li SX, Lin H, Xu X, Furberg CD, Davis BR, Pressel SL, Coifman RR, Krumholz HM.

Hypertension. 2017 Jul;70(1):94-102. doi: 10.1161/HYPERTENSIONAHA.117.09221. Epub 2017 May 30.

9.

Discovery of temporal and disease association patterns in condition-specific hospital utilization rates.

Haimovich JS, Venkatesh AK, Shojaee A, Coppi A, Warner F, Li SX, Krumholz HM.

PLoS One. 2017 Mar 29;12(3):e0172049. doi: 10.1371/journal.pone.0172049. eCollection 2017.

10.

Prediction of Adverse Events in Patients Undergoing Major Cardiovascular Procedures.

Mortazavi BJ, Desai N, Zhang J, Coppi A, Warner F, Krumholz HM, Negahban S.

IEEE J Biomed Health Inform. 2017 Nov;21(6):1719-1729. doi: 10.1109/JBHI.2017.2675340. Epub 2017 Mar 1.

PMID:
28287993
11.

Early Administration of Gabapentinoids Improves Motor Recovery after Human Spinal Cord Injury.

Warner FM, Cragg JJ, Jutzeler CR, Röhrich F, Weidner N, Saur M, Maier DD, Schuld C; EMSCI Sites, Curt A, Kramer JK.

Cell Rep. 2017 Feb 14;18(7):1614-1618. doi: 10.1016/j.celrep.2017.01.048.

12.

Thermal grill conditioning: Effect on contact heat evoked potentials.

Jutzeler CR, Warner FM, Wanek J, Curt A, Kramer JL.

Sci Rep. 2017 Jan 12;7:40007. doi: 10.1038/srep40007.

13.

Journal Club: Pregnancy outcome following maternal exposure to pregabalin may call for concern.

Jutzeler CR, Cragg JJ, Warner FM, Archibald J, Thomas CP, Elliott S, Kramer JL.

Neurology. 2017 Jan 3;88(1):e5-e7. doi: 10.1212/WNL.0000000000003458. No abstract available.

14.

A Forward Genetic Screen and Whole Genome Sequencing Identify Deflagellation Defective Mutants in Chlamydomonas, Including Assignment of ADF1 as a TRP Channel.

Hilton LK, Meili F, Buckoll PD, Rodriguez-Pike JC, Choutka CP, Kirschner JA, Warner F, Lethan M, Garces FA, Qi J, Quarmby LM.

G3 (Bethesda). 2016 Oct 13;6(10):3409-3418. doi: 10.1534/g3.116.034264.

15.

Meta-analysis of placebo responses in central neuropathic pain: impact of subject, study, and pain characteristics.

Cragg JJ, Warner FM, Finnerup NB, Jensen MP, Mercier C, Richards JS, Wrigley P, Soler D, Kramer JL.

Pain. 2016 Mar;157(3):530-40. doi: 10.1097/j.pain.0000000000000431. Review.

PMID:
26588698
16.

Correction: Spinal Cord Injury and Migraine Headache: A Population-Based Study.

Warner FM, Cragg JJ, Weisskopf MG, Kramer JK.

PLoS One. 2015 Sep 22;10(9):e0139181. doi: 10.1371/journal.pone.0139181. eCollection 2015. No abstract available.

17.

Circulating CD147 predicts mortality in advanced hepatocellular carcinoma.

Lee A, Rode A, Nicoll A, Maczurek AE, Lim L, Lim S, Angus P, Kronborg I, Arachchi N, Gorelik A, Liew D, Warner FJ, McCaughan GW, McLennan SV, Shackel NA.

J Gastroenterol Hepatol. 2016 Feb;31(2):459-66. doi: 10.1111/jgh.13148.

PMID:
26312403
18.

Spinal Cord Injury and Migraine Headache: A Population-Based Study.

Warner FM, Cragg JJ, Weisskopf MG, Kramer JK.

PLoS One. 2015 Aug 26;10(8):e0135550. doi: 10.1371/journal.pone.0135550. eCollection 2015. Erratum in: PLoS One. 2015;10(9):e0139181.

19.

Hepatocytes in liver injury: Victim, bystander, or accomplice in progressive fibrosis?

Tu T, Calabro SR, Lee A, Maczurek AE, Budzinska MA, Warner FJ, McLennan SV, Shackel NA.

J Gastroenterol Hepatol. 2015 Dec;30(12):1696-704. doi: 10.1111/jgh.13065. Review.

PMID:
26239824
20.

A Canada-wide survey of chronic respiratory disease and spinal cord injury.

Cragg JJ, Warner FM, Kramer JK, Borisoff JF.

Neurology. 2015 Mar 31;84(13):1341-5. doi: 10.1212/WNL.0000000000001428. Epub 2015 Feb 27.

PMID:
25724232
21.

Analysis of Post-Liver Transplant Hepatitis C Virus Recurrence Using Serial Cluster of Differentiation Antibody Microarrays.

Rahman W, Tu T, Budzinska M, Huang P, Belov L, Chrisp JS, Christopherson RI, Warner FJ, Bowden DS, Thompson AJ, Bowen DG, Strasser SI, Koorey D, Sharland AF, Yang JY, McCaughan GW, Shackel NA.

Transplantation. 2015 Sep;99(9):e120-6. doi: 10.1097/TP.0000000000000617.

PMID:
25706280
22.

Hepatocyte produced matrix metalloproteinases are regulated by CD147 in liver fibrogenesis.

Calabro SR, Maczurek AE, Morgan AJ, Tu T, Wen VW, Yee C, Mridha A, Lee M, d'Avigdor W, Locarnini SA, McCaughan GW, Warner FJ, McLennan SV, Shackel NA.

PLoS One. 2014 Jul 30;9(7):e90571. doi: 10.1371/journal.pone.0090571. eCollection 2014.

23.

Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development.

Tu T, Budzinska MA, Maczurek AE, Cheng R, Di Bartolomeo A, Warner FJ, McCaughan GW, McLennan SV, Shackel NA.

Int J Mol Sci. 2014 May 27;15(6):9422-58. doi: 10.3390/ijms15069422. Review.

24.

The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury.

Grzelak CA, Martelotto LG, Sigglekow ND, Patkunanathan B, Ajami K, Calabro SR, Dwyer BJ, Tirnitz-Parker JE, Watkins DN, Warner FJ, Shackel NA, McCaughan GW.

J Hepatol. 2014 Jan;60(1):143-51. doi: 10.1016/j.jhep.2013.08.012. Epub 2013 Aug 23.

PMID:
23978713
25.

The role of CD147 in liver injury: "The truth is in the details".

McLennan SV, Warner FJ, Shackel NA.

J Hepatol. 2013 Apr;58(4):836-7. doi: 10.1016/j.jhep.2012.11.029. Epub 2012 Nov 27. No abstract available.

26.

Analysis of human liver disease using a cluster of differentiation (CD) antibody microarray.

Rahman W, Huang P, Belov L, Chrisp JS, Christopherson RI, Stapelberg PM, Warner FJ, George J, Bowen DG, Strasser SI, Koorey D, Sharland AF, McCaughan GW, Shackel NA.

Liver Int. 2012 Nov;32(10):1527-34. doi: 10.1111/j.1478-3231.2012.02854.x. Epub 2012 Aug 3.

PMID:
22863037
27.

Determination of the exact molecular requirements for type 1 angiotensin receptor epidermal growth factor receptor transactivation and cardiomyocyte hypertrophy.

Smith NJ, Chan HW, Qian H, Bourne AM, Hannan KM, Warner FJ, Ritchie RH, Pearson RB, Hannan RD, Thomas WG.

Hypertension. 2011 May;57(5):973-80. doi: 10.1161/HYPERTENSIONAHA.110.166710. Epub 2011 Mar 7.

28.

Monocyte CD147 is induced by advanced glycation end products and high glucose concentration: possible role in diabetic complications.

Bao W, Min D, Twigg SM, Shackel NA, Warner FJ, Yue DK, McLennan SV.

Am J Physiol Cell Physiol. 2010 Nov;299(5):C1212-9. doi: 10.1152/ajpcell.00228.2010. Epub 2010 Sep 1.

29.

Bone marrow stem cells and the liver: are they relevant?

Eckersley-Maslin MA, Warner FJ, Grzelak CA, McCaughan GW, Shackel NA.

J Gastroenterol Hepatol. 2009 Oct;24(10):1608-16. doi: 10.1111/j.1440-1746.2009.06004.x. Review.

PMID:
19788602
30.

Quenched fluorescent peptide substrates as tools for the discovery of novel cardiovascular disease biomarkers.

Smith AI, Warner FJ, Lew RA, Yarski M, McGrath B, Burrell LM.

Adv Exp Med Biol. 2009;611:419-22. No abstract available.

PMID:
19400248
31.

Metabolic effects of low dose angiotensin converting enzyme inhibitor in dietary obesity in the rat.

Velkoska E, Warner FJ, Cole TJ, Smith I, Morris MJ.

Nutr Metab Cardiovasc Dis. 2010 Jan;20(1):49-55. doi: 10.1016/j.numecd.2009.02.004. Epub 2009 Apr 9.

PMID:
19361967
32.

Hepatocellular carcinoma development requires hepatic stem cells with altered transforming growth factor and interleukin-6 signaling.

Shackel NA, McCaughan GW, Warner FJ.

Hepatology. 2008 Jun;47(6):2134-6. doi: 10.1002/hep.22369. No abstract available.

PMID:
18508299
33.

The role of electromagnetic stimulation in the management of established non-union of long bone fractures: what is the evidence?

Griffin XL, Warner F, Costa M.

Injury. 2008 Apr;39(4):419-29. doi: 10.1016/j.injury.2007.12.014. Epub 2008 Mar 5. Review.

PMID:
18321512
34.

Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor.

Lew RA, Warner FJ, Hanchapola I, Yarski MA, Ramchand J, Burrell LM, Smith AI.

Exp Physiol. 2008 May;93(5):685-93. doi: 10.1113/expphysiol.2007.040352. Epub 2008 Jan 25. Erratum in: Exp Physiol. 2015 Aug;100(8):988. Manohar, Jay [corrected to Ramchand, Jay].

35.

Identification of resident hepatic stem cell populations.

Shackel NA, Warner FJ.

Hepatology. 2007 Dec;46(6):2042-4. No abstract available.

PMID:
18046721
36.

Tachykinin NK2 receptor and functional mechanisms in human colon: changes with indomethacin and in diverticular disease and ulcerative colitis.

Burcher E, Shang F, Warner FJ, Du Q, Lubowski DZ, King DW, Liu L.

J Pharmacol Exp Ther. 2008 Jan;324(1):170-8. Epub 2007 Oct 24.

37.

Social support and distress among Q'eqchi' refugee women in Maya TecĂșn, Mexico.

Warner FR.

Med Anthropol Q. 2007 Jun;21(2):193-217.

PMID:
17601084
38.

Liver fibrosis: a balance of ACEs?

Warner FJ, Lubel JS, McCaughan GW, Angus PW.

Clin Sci (Lond). 2007 Aug;113(3):109-18. Review.

PMID:
17600527
39.

Claudin-1, a new junction in the hepatitis C virus entry pathway.

Beard MR, Warner FJ.

Hepatology. 2007 Jul;46(1):277-9. No abstract available.

PMID:
17596888
40.

Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis.

Herath CB, Warner FJ, Lubel JS, Dean RG, Jia Z, Lew RA, Smith AI, Burrell LM, Angus PW.

J Hepatol. 2007 Sep;47(3):387-95. Epub 2007 Apr 2.

PMID:
17532087
41.

Liver anti-inflammatory pathways: potential ways to control liver damage.

Warner FJ.

Hepatology. 2007 May;45(5):1327-9. No abstract available.

PMID:
17464977
42.

Fooling the liver: malaria incognito.

Gorrell MD, Warner FJ.

Hepatology. 2007 Mar;45(3):826. No abstract available.

PMID:
17326213
43.

Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2.

Paizis G, Tikellis C, Cooper ME, Schembri JM, Lew RA, Smith AI, Shaw T, Warner FJ, Zuilli A, Burrell LM, Angus PW.

Gut. 2005 Dec;54(12):1790-6. Epub 2005 Sep 15.

44.

Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells.

Warner FJ, Lew RA, Smith AI, Lambert DW, Hooper NM, Turner AJ.

J Biol Chem. 2005 Nov 25;280(47):39353-62. Epub 2005 Sep 15.

45.

Membrane-associated zinc peptidase families: comparing ACE and ACE2.

Guy JL, Lambert DW, Warner FJ, Hooper NM, Turner AJ.

Biochim Biophys Acta. 2005 Aug 1;1751(1):2-8. Epub 2004 Nov 6. Review.

PMID:
16054014
46.

Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2).

Lambert DW, Yarski M, Warner FJ, Thornhill P, Parkin ET, Smith AI, Hooper NM, Turner AJ.

J Biol Chem. 2005 Aug 26;280(34):30113-9. Epub 2005 Jun 27.

47.

Geometric diffusions as a tool for harmonic analysis and structure definition of data: diffusion maps.

Coifman RR, Lafon S, Lee AB, Maggioni M, Nadler B, Warner F, Zucker SW.

Proc Natl Acad Sci U S A. 2005 May 24;102(21):7426-31. Epub 2005 May 17.

48.

Geometric diffusions as a tool for harmonic analysis and structure definition of data: multiscale methods.

Coifman RR, Lafon S, Lee AB, Maggioni M, Nadler B, Warner F, Zucker SW.

Proc Natl Acad Sci U S A. 2005 May 24;102(21):7432-7. Epub 2005 May 17.

49.

Angiotensin-converting enzyme-2: a molecular and cellular perspective.

Warner FJ, Smith AI, Hooper NM, Turner AJ.

Cell Mol Life Sci. 2004 Nov;61(21):2704-13. Review.

PMID:
15549171
50.

Human tachykinin NK2 receptor: a comparative study of the colon and urinary bladder.

Warner FJ, Miller RC, Burcher E.

Clin Exp Pharmacol Physiol. 2003 Sep;30(9):632-9.

PMID:
12940880

Supplemental Content

Loading ...
Support Center